Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

ET antagonists may have therapeutic role in diabetic erectile dysfunction

June 6, 2001

Patent covers Ferring's new vasopressin V2 receptor agonists and uses

June 5, 2001

Palatin's PT-141 ED treatment well tolerated in phase I trial

June 5, 2001

AUA news: AII antagonist, ACE inhibitor protect against postischemic acute renal failure

June 5, 2001

Superior side effect profile of tolterodine vs. oxybutynin in overactive bladder

June 1, 2001

Potent new PDE5 inhibitors designed by Pfizer group

May 30, 2001

Takeda's Ixense approved in Europe for ED

May 30, 2001

Pfizer describes potent new phosphodiesterase inhibitors and potential therapeutic uses

May 29, 2001

Merck presents amine derivatives with PDE5-inhibitory effects

May 21, 2001

Preparation and therapeutic uses of new alpha1A-adrenoceptor antagonists disclosed by Synaptic

May 18, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...